Table III.
Adverse events (CTCAE, version 3.0).
| Grade | |||
|---|---|---|---|
|
|
|||
| Adverse events | 1–2 (%) | 3 (%) | 4 (%) |
| Leukopenia | 26.0 | 50.0 | 8.0 |
| Neutropenia | 6.0 | 14.0 | 66.0 |
| Anemia | 62.0 | 10.0 | 6.0 |
| Thrombocytopenia | 30.0 | 4.0 | 0.0 |
| Febrile neutropenia | 0.0 | 6.0 | 2.0 |
| Anorexia | 55.0 | 12.0 | 0.0 |
| Nausea/vomiting | 48.0 | 8.0 | 0.0 |
| Diarrhea | 18.0 | 4.0 | 0.0 |
| Fever | 28.0 | 4.0 | 0.0 |
| Alopecia | 44.0 | 2.0 | 0.0 |
| Neuropathy | 10.0 | 2.0 | 0.0 |
| Myopathy | 0.0 | 2.0 | 0.0 |
| Angina pectoris | 0.0 | 2.0 | 0.0 |
| Aphtha | 16.0 | 0.0 | 0.0 |
| Skin rash | 2.0 | 0.0 | 0.0 |
| Arthralgia | 2.0 | 0.0 | 0.0 |
| Thrombosis | 2.0 | 0.0 | 0.0 |
CTCAE, Common Terminology Criteria for Adverse Events.